investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Metabolic control of hepatocellular carcinoma by PGC1alpha
Geoffrey D Girnun
2 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Daniel Metzger
Institute of Genetics and Molecular and Cellular Biology
Illkirch-Graffenstaden, France
Julie St. Pierre
McGill University
Montreal, Canada
Geoffrey D Girnun
Stony Brook University
Stony Brook, United States
Related projects
Gregory F Oxenkrug
Depression, insulin resistance and xanthurenic acid in hepatitis C virus patients
Liver and intrahepatic bile ducts
Pathology
Xin Wei Wang
Molecular signatures for Liver cancer diagnosis and treatment stratification
Liver and intrahepatic bile ducts
Pathology
Mitchell Ho
Development of antibody-based cancer therapies
Liver and intrahepatic bile ducts
Pathology
Frank Gonzalez
Xenobiotic Receptors – Rockville
Liver and intrahepatic bile ducts
Pathology
Snorri Thorgeirsson
Cancer Stem Cells and Human Liver Cancer
Liver and intrahepatic bile ducts
Pathology
Tim Greten
Immune Suppressor Mechanism Analysis in Patients with Hepatocellular Carcinoma
Liver and intrahepatic bile ducts
Pathology
John Tavis
HBV Drug Development
Liver and intrahepatic bile ducts
Pathology
Xin Wei Wang
Molecular signatures for liver cancer diagnosis and treatment stratification
Liver and intrahepatic bile ducts
Pathology
John Tavis
N-hydroxyisoquinolinediones as HCC Preventatives
Liver and intrahepatic bile ducts
Pathology
